Institutional shares held 19.8 Million
9.3K calls
100 puts
Total value of holdings $19M
$8K calls
$0 puts
Market Cap $53.9M
56,769,100 Shares Out.
Institutional ownership 34.85%
# of Institutions 56


Latest Institutional Activity in KRON

Top Purchases

Q3 2024
Siren, L.L.C. Shares Held: 843K ($801K)
Q3 2024
Woodline Partners LP Shares Held: 310K ($294K)
Q3 2024
Renaissance Technologies LLC Shares Held: 979K ($930K)
Q3 2024
Millennium Management LLC Shares Held: 2.05M ($1.94M)
Q3 2024
Acuitas Investments, LLC Shares Held: 555K ($527K)

Top Sells

Q3 2024
Citadel Advisors LLC Shares Held: 87.2K ($82.8K)
Q3 2024
Bridgeway Capital Management, LLC Shares Held: 119K ($113K)
Q3 2024
Partners Capital Investment Group, LLP Shares Held: 1.61M ($1.53M)
Q3 2024
Susquehanna International Group, LLP Shares Held: 50.2K ($47.7K)
Q3 2024
Forefront Analytics, LLC Shares Held: 91K ($86.4K)

About KRON

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase inhibitor for acute myeloid leukemia patients. The company planned registrational phase 3 clinical trial of ENTO in combination with induction chemotherapy in acute myeloid leukemia patients with NPM1 mutations. It is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors, which is in phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in San Mateo, California.


Insider Transactions at KRON

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
4.07M Shares
From 4 Insiders
Grant, award, or other acquisition 446K shares
Open market or private purchase 3.62M shares
Sell / Disposition
61.6K Shares
From 6 Insiders
Open market or private sale 61.6K shares

Track Institutional and Insider Activities on KRON

Follow Kronos Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRON shares.

Notify only if

Insider Trading

Get notified when an Kronos Bio, Inc. insider buys or sells KRON shares.

Notify only if

News

Receive news related to Kronos Bio, Inc.

Track Activities on KRON